Table 2.
Baseline characteristics and co-morbidities of cancer patients with and without a diagnosis of atrial fibrillation.
| Results |
Cancer patients with atrial fibrillation (n = 338) |
Cancer patients without atrial fibrillation (n = 7,461) |
P-value (2-sided) |
|---|---|---|---|
| Race: African American White Others |
45.3% 52.7% |
48.5% 49.3% |
0.489* |
| Sex: Male | 55.0% | 38.9% | <0.001 |
| CAD | 18.0% | 4.6% | <0.001 |
| Type: Solid Hematological Both |
72.2% 16.9% 10.9% |
72.3% 17.9% 9.8% |
0.74* |
| Myocardial infarction | 10.0% | 2.4% | <0.001 |
| CHF | 5.0% | 0.7% | <0.001 |
| Hypertension | 57.7% | 42% | <0.001 |
| TIA/ischemic stroke | 7.1% | 3.7% | 0.003 |
| Intra cranial hemorrhage | 1.8% | 0.9% | 0.13 |
| Diabetes mellitus | 25.7% | 16.8% | <0.001 |
| DVT/PE | 10.7% | 5.1% | <0.001 |
| OSA | 0.9% | 0.4% | 0.18 |
| CKD | 5.0% | 2.6% | 0.02 |
| ESRD | 3.0% | 0.8% | 0.001 |
| COPD | 2.7% | 0.8% | 0.003 |
CAD, coronary artery disease; CHF, congestive heart failure; DVT/PE, deep venous thrombosis/pulmonary embolism; OSA, obstructive sleep apnea; CKD, chronic kidney disease; ESRD, end stage renal disease; COPD, chronic obstructive pulmonary disease.
*
Pearson's chi-square test.